Leigh MacMillan

April 14, 2017

A new mode of DNA repair

Structural details of a protein that removes DNA lesions shed light on fundamental mechanisms of DNA repair.

By Leigh MacMillan
April 3, 2017

Fighting fungal infections

A detailed structural and functional analysis of the yeast protein that is the main target of antifungal drugs will help direct efforts to develop better treatments.

By Leigh MacMillan
March 30, 2017

Molecular motors expert Spudich set for next Discovery Lecture

James Spudich, Ph.D., renowned for his studies of proteins that function as molecular motors, will deliver the next Flexner Discovery Lecture on Thursday, April 6.

By Leigh MacMillan
March 22, 2017

Blocking neuroblastoma cell growth

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths.

By Leigh MacMillan
middle aged african american man outdoors
March 8, 2017

Role for mouth microbes in diabetes?

A higher abundance of certain bacterial species in the mouth appears to reduce the risk of type 2 diabetes, Vanderbilt investigators have discovered.

By Leigh MacMillan
March 7, 2017

Antidote for smoke inhalation injury

Routine use of hydroxocobalamin should be considered for victims of smoke inhalation, Vanderbilt researchers suggest.

By Leigh MacMillan
March 2, 2017

Retroviruses expert Bieniasz set for next Discovery Lecture

Paul Bieniasz, Ph.D., a pioneer in the study of retroviruses, will deliver the next Flexner Discovery Lecture on Thursday, March 9.
By Leigh MacMillan
March 2, 2017

Investigators seek new way to define cell identity

Vanderbilt researchers hope their new method to describe cells will be widely adopted and used to generate a “Who’s Who” database of cell types.
By Leigh MacMillan
February 23, 2017

A target to heal tiny lungs

The protein beta-catenin may be a good target for therapies to treat lung disease that is a common complication of preterm birth.
By Leigh MacMillan
February 20, 2017

Improving therapies for GI tumors

A signaling protein overexpressed in upper gastrointestinal cancers is an attractive therapeutic target.
By Leigh MacMillan
February 16, 2017

Neurologist Dalmau set for next Discovery Lecture

Josep Dalmau, M.D., Ph.D., renowned for his studies of immune disorders affecting the brain and spinal cord, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 23.
By Leigh MacMillan
February 8, 2017

Pathology of septic shock

The signaling molecule IL-15 promotes septic shock, a life-threatening condition involving organ injury caused by infection.
By Leigh MacMillan
1 … 39 40 41 42 43 … 75